Increased proportion of CD226 + CD14 + monocytes correlates with clinical features and laboratory parameters in patients with primary Sjögren's syndrome
ConclusionOur study suggested that an increased CD226 proportion on CD14 + monocytes was associated with the clinical manifestations, disease activity, and prognosis of pSS patients. CD226+ CD14 + monocytes may present a potential target and a biomarker for the prognosis and therapy of pSS patients.
Source: International Journal of Rheumatic Diseases - Category: Rheumatology Authors: Ping Zhao,
Wei Cheng,
Cuiping Liu,
Cheng Peng,
Yu Shen,
Yanhong Yang,
Chao Sun,
Xin Chang,
Jian Wu Tags: ORIGINAL ARTICLE Source Type: research
More News: Autoimmune Disease | Interstitial Lung Disease | Laboratory Medicine | Rheumatology | Study